Literature DB >> 25908506

Effect of Vitamin D3 Supplementation in Combination with Weight Loss on Inflammatory Biomarkers in Postmenopausal Women: A Randomized Controlled Trial.

Catherine Duggan1, Jean de Dieu Tapsoba2, Caitlin Mason2, Ikuyo Imayama2, Larissa Korde3, Ching-Yun Wang3, Anne McTiernan3.   

Abstract

Obesity and vitamin D deficiency are associated with risk for several cancers, possibly through inflammation and adipokine-related pathways. Two hundred and eighteen postmenopausal women with BMI > 25 kg/m(2) and low serum 25-hydroxyvitamin D (25(OH)D; ≥10-<32 ng/mL), were randomized to 12 months of either (i) weight-loss intervention + 2000 IU/day oral vitamin D3 or (ii) weight-loss intervention + daily placebo. Serum adiponectin, leptin, TNFα, IL6, IL1β, IL8, and IL10, were measured by immunoassay, and a composite inflammatory biomarker score calculated. Using generalized estimating equations, mean changes in outcomes were compared between arms (intent-to-treat), adjusted for possible confounders. Analyses were also stratified by weight-loss (gained/no weight-loss; <5%; 5% to 10%; ≥10%). At 12 months, there were no significant differences in analyte changes between arms. In stratified analyses, participants randomized to vitamin D3 who lost 5% to 10% of baseline weight, versus participants who gained weight/had no weight-loss, had significantly greater decreases in levels of IL6 compared with those randomized to placebo: absolute change -0.75 pg/mL (-17.2%), placebo versus -1.77 pg/mL (-37.3%), vitamin D, P = 0.004. Similar but attenuated results were observed for participants who lost ≥10% of baseline weight: -0.41 pg/mL (-13.6%), placebo versus -0.67 pg/mL (-17.3%), vitamin D, P = 0.02. Effects of vitamin D3 supplementation on levels of IL1β were inconsistent when stratified by weight loss. There were no intervention effects on IL10, TNFα, IL8, the composite score, adiponectin, or leptin, when stratified by weight-loss. In conclusion, vitamin D3 supplementation in combination with weight-loss of at least 5% of baseline weight was associated with significant reductions in levels of IL6. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25908506      PMCID: PMC4491001          DOI: 10.1158/1940-6207.CAPR-14-0449

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  55 in total

Review 1.  Meta-analysis: serum vitamin D and breast cancer risk.

Authors:  Lu Yin; Norma Grandi; Elke Raum; Ulrike Haug; Volker Arndt; Hermann Brenner
Journal:  Eur J Cancer       Date:  2010-04-22       Impact factor: 9.162

Review 2.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

3.  No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects.

Authors:  Rolf Jorde; Monica Sneve; Peter A Torjesen; Yngve Figenschau; Lasse G Gøransson; Roald Omdal
Journal:  Cytokine       Date:  2010-02-01       Impact factor: 3.861

Review 4.  Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin.

Authors:  Peter J Havel
Journal:  Curr Opin Lipidol       Date:  2002-02       Impact factor: 4.776

5.  Receipt of psychosocial care among cancer survivors in the United States.

Authors:  Laura P Forsythe; Erin E Kent; Kathryn E Weaver; Natasha Buchanan; Nikki A Hawkins; Juan L Rodriguez; A Blythe Ryerson; Julia H Rowland
Journal:  J Clin Oncol       Date:  2013-04-22       Impact factor: 44.544

6.  Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes.

Authors:  Donna H Ryan; Mark A Espeland; Gary D Foster; Steven M Haffner; Van S Hubbard; Karen C Johnson; Steven E Kahn; William C Knowler; Susan Z Yanovski
Journal:  Control Clin Trials       Date:  2003-10

7.  Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial.

Authors:  Anthony M Belenchia; Aneesh K Tosh; Laura S Hillman; Catherine A Peterson
Journal:  Am J Clin Nutr       Date:  2013-02-13       Impact factor: 7.045

Review 8.  Survivorship: adult cancer survivors.

Authors:  Patricia A Ganz
Journal:  Prim Care       Date:  2009-12       Impact factor: 2.907

9.  Interleukin-1beta and fibroblast growth factor receptor 1 cooperate to induce cyclooxygenase-2 during early mammary tumourigenesis.

Authors:  Johanna R Reed; Ronald P Leon; Majken K Hall; Kathryn L Schwertfeger
Journal:  Breast Cancer Res       Date:  2009-04-24       Impact factor: 6.466

10.  Optimising the quantification of cytokines present at low concentrations in small human mucosal tissue samples using Luminex assays.

Authors:  Emily Staples; Richard James Michael Ingram; John Christopher Atherton; Karen Robinson
Journal:  J Immunol Methods       Date:  2013-05-01       Impact factor: 2.303

View more
  14 in total

1.  Evidence-based nutritional and pharmacological interventions targeting chronic low-grade inflammation in middle-age and older adults: A systematic review and meta-analysis.

Authors:  C Custodero; R T Mankowski; S A Lee; Z Chen; S Wu; T M Manini; J Hincapie Echeverri; C Sabbà; D P Beavers; J A Cauley; M A Espeland; R A Fielding; S B Kritchevsky; C K Liu; M M McDermott; M E Miller; R P Tracy; A B Newman; W T Ambrosius; M Pahor; S D Anton
Journal:  Ageing Res Rev       Date:  2018-05-25       Impact factor: 10.895

Review 2.  Causes of Vitamin D Deficiency and Effect of Vitamin D Supplementation on Metabolic Complications in Obesity: a Review.

Authors:  Louise Wamberg; Steen B Pedersen; Lars Rejnmark; Bjørn Richelsen
Journal:  Curr Obes Rep       Date:  2015-12

Review 3.  A systematic review of the interrelation between diet- and surgery-induced weight loss and vitamin D status.

Authors:  Caroline Himbert; Jennifer Ose; Mahmoud Delphan; Cornelia M Ulrich
Journal:  Nutr Res       Date:  2016-12-08       Impact factor: 3.315

Review 4.  The effect of vitamin D supplementation on selected inflammatory biomarkers in obese and overweight subjects: a systematic review with meta-analysis.

Authors:  Małgorzata Jamka; Małgorzata Woźniewicz; Jarosław Walkowiak; Paweł Bogdański; Jan Jeszka; Marta Stelmach-Mardas
Journal:  Eur J Nutr       Date:  2015-11-04       Impact factor: 5.614

5.  Cholecalciferol Supplementation Does Not Prevent the Development of Metabolic Syndrome or Enhance the Beneficial Effects of Omega-3 Fatty Acids in Obese Mice.

Authors:  Marion Valle; Patricia L Mitchell; Geneviève Pilon; Philippe St-Pierre; Thibault Varin; Denis Richard; Marie-Claude Vohl; Hélène Jacques; Edgar Delvin; Emile Levy; Claudia Gagnon; Laurent Bazinet; André Marette
Journal:  J Nutr       Date:  2021-05-11       Impact factor: 4.798

Review 6.  An Updated Mini Review of Vitamin D and Obesity: Adipogenesis and Inflammation State.

Authors:  Zujaja-Tul-Noor Hamid Mehmood; Dimitrios Papandreou
Journal:  Open Access Maced J Med Sci       Date:  2016-09-06

7.  The Effect of Serum 25-Hydroxyvitamin D Concentrations on Elevated Serum C-Reactive Protein Concentrations in Normal Weight, Overweight and Obese Participants of a Preventive Health Program.

Authors:  Silmara S B S Mastroeni; Lalani L Munasinghe; Truong-Minh Pham; Sarah A Loehr; John Paul Ekwaru; Marco F Mastroeni; Paul J Veugelers
Journal:  Nutrients       Date:  2016-11-04       Impact factor: 5.717

8.  Gene expression in breast and adipose tissue after 12 months of weight loss and vitamin D supplementation in postmenopausal women.

Authors:  Larissa A Korde; Anne McTiernan; Caitlin Mason; Lei Wang; Catherine Duggan; Ikuyo Imayama; Sushma S Thomas; Ching-Yun Wang
Journal:  NPJ Breast Cancer       Date:  2017-04-21

9.  Acute Vitamin D₃ Supplementation in Severe Obesity: Evaluation of Multimeric Adiponectin.

Authors:  Stefania Mai; Gillian E Walker; Roberta Vietti; Stefania Cattaldo; Chiara Mele; Lorenzo Priano; Alessandro Mauro; Gianni Bona; Gianluca Aimaretti; Massimo Scacchi; Paolo Marzullo
Journal:  Nutrients       Date:  2017-05-05       Impact factor: 5.717

10.  1,25(OH)2D3 treatment attenuates high glucose‑induced peritoneal epithelial to mesenchymal transition in mice.

Authors:  Lina Yang; Yi Fan; Xiuli Zhang; Wenyu Huang; Jianfei Ma
Journal:  Mol Med Rep       Date:  2017-07-27       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.